|
시장보고서
상품코드
1421824
hERG 스크리닝 시장, 점유율, 규모, 동향, 산업 분석 리포트 : 제품 유형별, 이온채널별, 용도별, 지역별, 부문별 예측(2024-2032년)HERG Screening Market Share, Size, Trends, Industry Analysis Report, By Product Type (Gene KCNH2, Mutant KCNH2, Others); By Ion Channel; By Application; By Region; Segment Forecast, 2024 - 2032 |
||||||
Polaris Market Research의 최신 조사에 따르면 세계의 hERG 스크리닝 시장 규모는 2032년까지 610만 달러에 달할 전망입니다. 이 조사 리포트는 현재의 시장 역학에 관한 상세 인사이트와 향후 시장 성장에 관한 분석을 제공하고 있습니다.
시장은 혁신적인 의약품의 승인 수 증가와 심장병 유병률 증가에 의해 주도되고 있으며, 2019년 전 세계에서 남성 960만 명, 여성 890만 명이 심혈관 질환으로 사망했으며, 그 중 30-70세 연령층이 600만 명을 넘어섰습니다. 이러한 사망자는 주로 인도, 러시아, 중국, 미국, 인도네시아에서 발생했습니다. 그럼에도 불구하고 미개척 시장은 곧 이 시장의 성장에 유리한 잠재력을 창출할 것으로 예상됩니다.
심장병 유병률 증가와 심장병 환자 수 증가는 시장 성장을 가속할 것으로 보입니다. 또한 인실리코 기술과 함께 신규 약물의 승인 증가도 시장 확대에 기여할 것으로 예상됩니다. 예를 들어 DrugBank 데이터베이스에서 잠재적인 hERG 차단제를 스크리닝하기 위해 머신러닝 기반 알고리즘 모델이 개발되고 있습니다. 그라데이션 부스팅 트리와 딥루트 신경 알고리즘을 결합하여 최첨단 머신러닝 모델을 만들었습니다.
최근 수년간 연구자들은 hERG K 채널의 과활성화를 피하면서 동시에 부정맥을 유발할 수 있는 새로운 약물을 시험하는 데 집중하고 있는데, 이는 hERG 차단이 사람의 "Torsades de Pointes"와 관련된 많은 부정맥 유발 물질의 공통된 특징이기 때문입니다.
심장 질환의 유병률 증가와 이를 치료할 수 있는 의약품의 개발은 hERG 검사 툴의 사용을 촉진할 수 있습니다. 또한 hERG 스크리닝 키트의 가격이 보다 합리적인 수준으로 낮아진 것도 hERG 스크리닝 키트의 사용을 늘리는 데 도움이 될 수 있습니다.
전염병 초기에는 환자의 COVID-19를 검출할 수 있는 정확한 진단 테스트가 없었고, COVID-19 진단 테스트가 없었기 때문에 진단약 제조업체들은 COVID-19 진단 키트를 만들어 이익을 얻을 수 있는 기회가 있다고 생각했습니다. 이들 기업은 COVID-19 진단키트 수요를 활용함으로써 다른 진단키트 제조업체보다 우위를 점할 수 있었고, 이러한 상황에서도 매출을 유지할 수 있었습니다. 빠른 C형 불활성화는 hERG 칼륨 채널에 특정한 기능적 특징을 제공하며, 유전성 부정맥 및 후천성 부정맥과의 관계로 인해 원자 수준에서 hERG 불활성화 메커니즘에 대한 연구가 중요해졌습니다.
hERG 스크리닝 시장 보고서 하이라이트
KCNH2 유전자는 칼륨 채널 명령을 암호화하는 광범위한 유전자 군의 일부이며, KCNH2 돌연변이는 심장 부정맥을 유발하기 때문에 시장 점유율을 크게 차지합니다.
전압 게이트 이온 채널은 가장 빠르게 성장하는 분야인 이온 게이트 채널과 함께 세계 시장을 독점하고 있습니다.
이온 채널의 기능적 활성을 변화시키는 항부정맥제 분야는 상당한 시장 점유율을 차지할 것으로 예상됩니다.
북미가 가장 큰 매출 점유율을 차지한 주요 이유는 주요 기업의 존재와 개인의 인지도 때문인 것으로 분석됩니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 세계의 hERG 스크리닝 시장 인사이트
- hERG 스크리닝 시장 - 용도 스냅숏
- hERG 스크리닝 시장 역학
- 촉진요인과 기회
- Drug Discovery와 개발의 증가
- 심혈관질환의 발생률 증가
- 억제요인과 과제
- 스크리닝 어세이의 고비용
- 촉진요인과 기회
- PESTEL 분석
- hERG 스크리닝 시장의 용도 동향
- 밸류체인 분석
- COVID-19의 영향 분석
제5장 세계의 hERG 스크리닝 시장, 제품 유형별
- 주요 조사 결과
- 서론
- KCNH2 유전자
- KCNH2 변이
- 기타
제6장 세계의 hERG 스크리닝 시장, 이온채널별
- 주요 조사 결과
- 서론
- 전압 게이트
- 리간드 게이트
- 기타
제7장 세계의 hERG 스크리닝 시장, 용도별
- 주요 조사 결과
- 서론
- 항부정맥약
- 항정신병약
- 항생제
- 기타
제8장 세계의 hERG 스크리닝 시장, 지역별
- 주요 조사 결과
- 서론
- hERG 스크리닝 시장 평가, 지역별, 2019-2032년
- hERG 스크리닝 시장 - 북미
- 북미 : hERG 스크리닝 시장, 제품 유형별, 2019-2032년
- 북미 : hERG 스크리닝 시장, 용도별, 2019-2032년
- 북미 : hERG 스크리닝 시장, 이온채널별, 2019-2032년
- hERG 스크리닝 시장 - 미국
- hERG 스크리닝 시장 - 캐나다
- hERG 스크리닝 시장 - 유럽
- 유럽 : hERG 스크리닝 시장, 제품 유형별, 2019-2032년
- 유럽 : hERG 스크리닝 시장, 용도별, 2019-2032년
- 유럽 : hERG 스크리닝 시장, 이온채널별, 2019-2032년
- hERG 스크리닝 시장 - 영국
- hERG 스크리닝 시장 - 프랑스
- hERG 스크리닝 시장 - 독일
- hERG 스크리닝 시장 - 이탈리아
- hERG 스크리닝 시장 - 스페인
- hERG 스크리닝 시장 - 네덜란드
- hERG 스크리닝 시장 - 러시아
- hERG 스크리닝 시장 - 아시아태평양
- 아시아태평양 : hERG 스크리닝 시장, 제품 유형별, 2019-2032년
- 아시아태평양 : hERG 스크리닝 시장, 용도별, 2019-2032년
- 아시아태평양 : hERG 스크리닝 시장, 이온채널별, 2019-2032년
- hERG 스크리닝 시장 - 중국
- hERG 스크리닝 시장 - 인도
- hERG 스크리닝 시장 - 말레이시아
- hERG 스크리닝 시장 - 일본
- hERG 스크리닝 시장 - 인도네시아
- hERG 스크리닝 시장 - 한국
- hERG 스크리닝 시장 - 중동 및 아프리카
- 중동 및 아프리카 : hERG 스크리닝 시장, 제품 유형별, 2019-2032년
- 중동 및 아프리카 : hERG 스크리닝 시장, 용도별, 2019-2032년
- 중동 및 아프리카 : hERG 스크리닝 시장, 이온채널별, 2019-2032년
- hERG 스크리닝 시장 - 사우디아라비아
- hERG 스크리닝 시장 - 아랍에미리트
- hERG 스크리닝 시장 - 이스라엘
- hERG 스크리닝 시장 - 남아프리카
- hERG 스크리닝 시장 - 라틴아메리카
- 라틴아메리카 : hERG 스크리닝 시장, 제품 유형별, 2019-2032년
- 라틴아메리카 : hERG 스크리닝 시장, 용도별, 2019-2032년
- 라틴아메리카 : hERG 스크리닝 시장, 이온채널별, 2019-2032년
- hERG 스크리닝 시장 - 멕시코
- hERG 스크리닝 시장 - 브라질
- hERG 스크리닝 시장 - 아르헨티나
제9장 경쟁 구도
- 확장과 인수의 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제10장 기업 개요
- Abcam PLC
- ABR-Affinity Bioreagents
- AstraZeneca
- Aureus Sciences
- Aurora Sciences
- AVIVA Biosciences
- B'SyS GmbH
- Caliper
- Cambridge Biosciences
- Cellular Dynamics
- ChanTest Corporation
- Charles River Laboratories
- ChemAxon
- Eurofins-Cerep SA
- Molecular Devices
- PerkinElmer Company
The global HERG screening market size is expected to reach USD 6.10 million by 2032, according to a new study by Polaris Market Research. The report "HERG Screening Market Share, Size, Trends, Industry Analysis Report, By Product Type (Gene KCNH2, Mutant KCNH2, Others); By Ion Channel; By Application; By Region; Segment Forecast, 2024-2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.
Market is being driven by the increasing number of innovative medication approvals and the rising prevalence of cardiac disorders. In 2019, 9.6 Mn men & 8.9 Mn women died from the cardiovascular diseases across the globe, with further than 6 Mn of them aged 30-70. Such deaths were majorly from India, Russia, China, United States, & Indonesia. Nonetheless, unexplored markets are anticipated to create a lucrative potential for this market's growth soon.
Rise in the incidence of heart illnesses and the number of people suffering from heart ailments are likely to drive market growth. Furthermore, a rise in the approvals of novel drug entities along with in silico techniques is projected to contribute in market expansion. For instance, machine learning based algorithmic models have been developed to screen the DrugBank database for the potential hERG blockers. To create cutting-edge machine learning models, were combined with gradient boosting tree & deep-rooted neural algorithms.
In recent years, researchers have concentrated on avoiding the hyper-activity of the hERG K+ channel while at the same time testing novel drugs for the pro-arrhythmic potential, as hERG block is a common characteristic of the many pro-arrhythmic substances linked with the "Torsades de Pointes" in people.
The rising prevalence of cardiac disease and medicine development to treat it may enhance the use of HERG screening tools. Furthermore, the drop in price to more reasonable levels may assist to increase the use of HERG screening kits.
There were no precise diagnostic tests available to detect COVID-19 in patients during the early stages of the epidemic. Because COVID-19 diagnostic tests were unavailable, diagnostic manufacturers saw profitable chances to create COVID-19 diagnostic kits. These firms gained an advantage over other diagnostics players by leveraging on demand for COVID-19 diagnostic tests, which enables them sustain revenues in such a situation. Fast C-type inactivation provides specific functional features to the hERG potassium channel, and its relationship with inherited and acquired cardiac arrhythmias makes atomic-level hERG inactivation mechanism research critical.
HERG Screening market Report Highlights
The KCNH2 gene is part of a wide family of genes that code for potassium channel instructions and a KCNH2 mutation causes cardiac arrhythmia, hence share a significant hold in the market share.
Voltage gated ion channels dominated the worldwide market, along with the fastest-growing sector which is ion gated channels.
The antiarrhythmic medication application sector is expected to account for a sizable market share as it modifies the functional activity of the ion channel.
North America accounted for the largest revenue share primarily due presence of key companies & awareness among individuals
The global players include: Abcam PLC, PerkinElmer Company, ABR-Affinity Bioreagents, AstraZeneca, Aureus Sciences, Aurora Sciences, AVIVA Biosciences, B'SyS GmbH, Caliper, Fujifilm Cellular Dynamics, Cambridge Biosciences, ChanTest Corporation, Charles River Laboratories, ChemAxon, Eurofins-Cerep, and Molecular Devices.
Polaris Market Research has segmented the HERG screening market report based on product type, ion channel, application, and region:
HERG Screening, Product Type Outlook (Revenue - USD Million, 2019 - 2032)
- Gene KCNH2
- Mutant KCNH2
- Others
HERG Screening, Ion Channel Outlook (Revenue - USD Million, 2019 - 2032)
- Voltage Gated
- Ligand Gated
- Others
HERG Screening, Application Outlook (Revenue - USD Million, 2019 - 2032)
- Antiarrhythmic
- Antipsychotic
- Antibiotic
- Others
HERG Screening, Regional Outlook (Revenue - USD Million, 2019 - 2032)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Netherlands
- Asia Pacific
- China
- India
- Japan
- South Korea
- Indonesia
- Malaysia
- Latin America
- Argentina
- Brazil
- Mexico
- Middle East & Africa
- UAE
- Saudi Arabia
- Israel
- South Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Global HERG Screening Market Insights
- 4.1. HERG Screening Market - Application Snapshot
- 4.2. HERG Screening Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Drug Discovery and Development
- 4.2.1.2. Rising Incidence of Cardiovascular Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Cost of Screening Assays
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. HERG Screening Market Application Trends
- 4.6. Value Chain Analysis
- 4.7. COVID-19 Impact Analysis
5. Global HERG Screening Market, by Product Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 5.3. Gene KCNH2
- 5.3.1. Global HERG Screening Market, by Gene KCNH2, by Region, 2019-2032 (USD Million)
- 5.4. Mutant KCNH2
- 5.4.1. Global HERG Screening Market, by Mutant KCNH2, by Region, 2019-2032 (USD Million)
- 5.5 Others
- 5.5.1. Global HERG Screening Market, by Others, by Region, 2019-2032 (USD Million)
6. Global HERG Screening Market, by Ion Channel
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 6.3. Voltage Gated
- 6.3.1. Global HERG Screening Market, by Voltage Gated, by Region, 2019-2032 (USD Million)
- 6.4. Ligand Gated
- 6.4.1. Global HERG Screening Market, by Ligand Gated, by Region, 2019-2032 (USD Million)
- 6.5. Others
- 6.5.1. Global HERG Screening Market, by Others, by Region, 2019-2032 (USD Million)
7. Global HERG Screening Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global HERG Screening Market, by Application, 2019-2032 (USD Million)
- 7.3. Antiarrhythmic
- 7.3.1. Global HERG Screening Market, by Antiarrhythmic, By Region, 2019-2032 (USD Million)
- 7.4. Antipsychotic
- 7.4.1. Global HERG Screening Market, by Antipsychotic, By Region, 2019-2032 (USD Million)
- 7.5. Antibiotic
- 7.5.1. Global HERG Screening Market, by Antibiotic, By Region, 2019-2032 (USD Million)
- 7.6. Others
- 7.6.1. Global HERG Screening Market, by Others, By Region, 2019-2032 (USD Million)
8. Global HERG Screening Market, by Geography
- 8.1. Key findings
- 8.2. Introduction
- 8.2.1. HERG Screening Market Assessment, By Geography, 2019-2032 (USD Million)
- 8.3. HERG Screening Market - North America
- 8.3.1. North America: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.2. North America: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.3. North America: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.3.4. HERG Screening Market - U.S.
- 8.3.4.1. U.S.: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.4.2. U.S.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.4.3. U.S.: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.3.5. HERG Screening Market - Canada
- 8.3.5.1. Canada: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.3.5.2. Canada.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.3.5.3. Canada: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4. HERG Screening Market - Europe
- 8.4.1. Europe: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.2. Europe.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.3. Europe: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.4. HERG Screening Market - UK
- 8.4.4.1. UK: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.4.2. UK.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.4.3. UK: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.5. HERG Screening Market - France
- 8.4.5.1. France: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.5.2. France.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.5.3. France: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.6. HERG Screening Market - Germany
- 8.4.6.1. Germany: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.6.2. Germany.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.6.3. Germany: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.7. HERG Screening Market - Italy
- 8.4.7.1. Italy: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.7.2. Italy.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.7.3. Italy: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.8. HERG Screening Market - Spain
- 8.4.8.1. Spain: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.8.2. Spain.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.8.3. Spain: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.9. HERG Screening Market - Netherlands
- 8.4.9.1. Netherlands: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.9.2. Netherlands.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.9.3. Netherlands: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.4.10. HERG Screening Market - Russia
- 8.4.10.1. Russia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.4.10.2. Russia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.4.10.3. Russia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5. HERG Screening Market - Asia Pacific
- 8.5.1. Asia Pacific: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.2. Asia Pacific.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.3. Asia Pacific: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.4. HERG Screening Market - China
- 8.5.4.1. China: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.4.2. China.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.4.3. China: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.5. HERG Screening Market - India
- 8.5.5.1. India: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.5.2. India.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.5.3. India: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.6. HERG Screening Market - Malaysia
- 8.5.6.1. Malaysia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.6.2. Malaysia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.6.3. Malaysia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.7. HERG Screening Market - Japan
- 8.5.7.1. Japan: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.7.2. Japan.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.7.3. Japan: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.8. HERG Screening Market - Indonesia
- 8.5.8.1. Indonesia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.8.2. Indonesia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.8.3. Indonesia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.5.9. HERG Screening Market - South Korea
- 8.5.9.1. South Korea: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.5.9.2. South Korea.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.5.9.3. South Korea: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6. HERG Screening Market - Middle East & Africa
- 8.6.1. Middle East & Africa: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.2. Middle East & Africa.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.3. Middle East & Africa: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.4. HERG Screening Market - Saudi Arabia
- 8.6.4.1. Saudi Arabia: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.4.2. Saudi Arabia.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.4.3. Saudi Arabia: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.5. HERG Screening Market - UAE
- 8.6.5.1. UAE: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.5.2. UAE.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.5.3. UAE: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.6. HERG Screening Market - Israel
- 8.6.6.1. Israel: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.6.2. Israel.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.6.3. Israel: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.6.7. HERG Screening Market - South Africa
- 8.6.7.1. South Africa: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.6.7.2. South Africa.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.6.7.3. South Africa: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7. HERG Screening Market - Latin America
- 8.7.1. Latin America: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.2. Latin America.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.3. Latin America: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.4. HERG Screening Market - Mexico
- 8.7.4.1. Mexico: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.4.2. Mexico.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.4.3. Mexico: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.5. HERG Screening Market - Brazil
- 8.7.5.1. Brazil: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.5.2. Brazil.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.5.3. Brazil: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
- 8.7.6. HERG Screening Market - Argentina
- 8.7.6.1. Argentina: HERG Screening Market, by Product Type, 2019-2032 (USD Million)
- 8.7.6.2. Argentina.: HERG Screening Market, by Application, 2019-2032 (USD Million)
- 8.7.6.3. Argentina: HERG Screening Market, by Ion Channel, 2019-2032 (USD Million)
9. Competitive Landscape
- 9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
- 9.2. Partnerships/Collaborations/Agreements/Exhibitions
10. Company Profiles
- 10.1. Abcam PLC
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Product Benchmarking
- 10.1.4. Recent Development
- 10.2. ABR-Affinity Bioreagents
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Product Benchmarking
- 10.2.4. Recent Development
- 10.3. AstraZeneca
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Product Benchmarking
- 10.3.4. Recent Development
- 10.4. Aureus Sciences
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Product Benchmarking
- 10.4.4. Recent Development
- 10.5. Aurora Sciences
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Product Benchmarking
- 10.5.4. Recent Development
- 10.6. AVIVA Biosciences
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Product Benchmarking
- 10.6.4. Recent Development
- 10.7. B'SyS GmbH
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Product Benchmarking
- 10.7.4. Recent Development
- 10.8. Caliper
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Product Benchmarking
- 10.8.4. Recent Development
- 10.9. Cambridge Biosciences
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Product Benchmarking
- 10.9.4. Recent Development
- 10.10. Cellular Dynamics
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Product Benchmarking
- 10.10.4. Recent Development
- 10.11. ChanTest Corporation
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Product Benchmarking
- 10.11.4. Recent Development
- 10.12. Charles River Laboratories
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Product Benchmarking
- 10.12.4. Recent Development
- 10.13. ChemAxon
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Product Benchmarking
- 10.13.4. Recent Development
- 10.14. Eurofins-Cerep SA
- 10.14.1. Company Overview
- 10.14.2. Financial Performance
- 10.14.3. Product Benchmarking
- 10.14.4. Recent Development
- 10.15. Molecular Devices
- 10.15.1. Company Overview
- 10.15.2. Financial Performance
- 10.15.3. Product Benchmarking
- 10.15.4. Recent Development
- 10.16. PerkinElmer Company
- 10.16.1. Company Overview
- 10.16.2. Financial Performance
- 10.16.3. Product Benchmarking
- 10.16.4. Recent Development
